Oruka Therapeutics (ORKA) Cash from Investing Activities (QoQ) (2011 - 2026)
Oruka Therapeutics (ORKA) Cash from Investing Activities (QoQ) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Oruka Therapeutics |
3.86 Bn |
3.47 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
34.44% |
| Dec 31, 2025 |
82.02% |
| Sep 30, 2025 |
-2,619.53% |
| Jun 30, 2025 |
-88.66% |
| Mar 31, 2025 |
112.99% |
| Dec 31, 2024 |
-192,856.73% |
| Mar 31, 2022 |
71.43% |
| Dec 31, 2021 |
50.00% |
| Sep 30, 2021 |
12.50% |
| Jun 30, 2021 |
-166.67% |
| Mar 31, 2021 |
53.85% |
| Jun 30, 2020 |
0.00% |
| Mar 31, 2020 |
-50.00% |
| Mar 31, 2018 |
-35.80% |
| Dec 31, 2017 |
609.55% |
| Sep 30, 2017 |
-115.28% |
| Jun 30, 2017 |
102.83% |
| Mar 31, 2017 |
-4.45% |
| Dec 31, 2016 |
223.55% |
| Sep 30, 2016 |
78.43% |
